The New Health Care: Why Preventing Cancer Is Not the Priority in Drug Development
Monday, December 28, 2015 - 13:20
in Health & Medicine
The profits lie in treating later-stage cancers; a study shows it’s because of the incentives in the interplay between the patent system and the F.D.A. approval process.